0000000000589103

AUTHOR

G Vessia

showing 2 related works from this author

“Bevacizumab (Bev) with irinotecan (IRI), folinic acid (FA), and 5-fluorouracil (FU) i.v. every 2 weeks (BIFF regimen) as first-line treatment for me…

2009

Settore MED/06 - Oncologia Medicabevacizumab metastatic colorectal cancer
researchProduct

“Bevacizumab (BEV),irinotecan (IRI), folinic acid (FA) and fluorouracil (FU) every 2 weeks (BIFF regimen) as first-line treatment for metastatic colo…

2009

Settore MED/06 - Oncologia Medicabevacizumabchemotherapymetastatic colorectal cancer
researchProduct